Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in

Beginner's Mind

Beginner's Mind artwork

EP 146: Bio Europe - Will Europe’s Biotech Future Survive? Inside the Funding and Talent Exodus

Nov 10, 202452 minAudio

Europe’s biotech sector is facing a crisis: despite its scientific achievements, it struggles with funding gaps and an exodus of top talent to the US. As biotech innovations drive global healthcare, Europe risks losing its edge - and the potential for groundbreaking medical advancements that affect us all. How can Europe regain its competitive advantage and transform scientific discoveries into real-world solutions? In this special episode from BIO-Europe’s 30th anniversary in Stockholm, industry veterans Cormac Sheridan, Jonathan Smith, Christian Soschner, and Mike Ward reveal the path forward. They tackle the critical challenges in Europe’s biotech landscape, from funding shortfalls and talent loss to opportunities in AI and the promise of global partnerships. Discover the strategies that could redefine Europe’s role in biotech and keep innovation thriving on the continent. 🎙️ What’s Inside: 1️⃣ The Funding Dilemma: Why Europe’s investment landscape hinders biotech and how new models could change the game. 2️⃣ Talent Exodus: How the brain drain to the US is affecting Europe’s biotech ambitions and what it takes to retain top innovators. 3️⃣ AI in Biotech: Uncover the power of AI and digital tools in transforming drug development and patient care in Europe. 4️⃣ Global Collaboration Opportunities: Why Europe needs to shift its focus eastward and the potential of partnerships beyond US borders. 👤 Meet the Panelists: Cormac Sheridan: A seasoned biotech journalist, covering industry trends for over two decades, who reminds us that biotech’s success is rooted in resilience: “Fail faster, fail better.” Jonathan Smith: Biotech correspondent with insights into the complex regulatory and financial hurdles in Europe’s biotech ecosystem. Christian Soschner: CEO and biotech advisor, who shares powerful strategies on funding, partnerships, and global competitiveness. Mike Ward: Renowned analyst with a keen eye on market dynamics and investment trends shaping the future of biotech. Millie Nelson: Panel Host 💡 QUOTES: (05:18) "The future of biotech lies in integrating AI into medicine - beyond the hype." - Cormac Sheridan (00:17:22) "Failure is embedded in biotech. It's a risk-based enterprise; success demands resilience." - Cormac Sheridan (00:22:39) "and this brain drain when someone has a great idea that has..." - Christian Soschner ⏰ Timestamps: (00:00) Meet the panelists - industry experts with decades of biotech insight (07:15) Innovative funding paths and geopolitical impacts in biotech (06:30) Navigating Global Investment Challenges (00:16:07) Europe's biotech strength - powerful innovation, but struggles with commercializing scientific breakthroughs (00:22:39) Brain drain in Europe - how US incentives pull top talent across the Atlantic (00:29:06) Neuroscience breakthroughs - positive signs for neurodegenerative disease treatments spark new interest (00:34:08) Europe’s opportunity - global collaboration could drive biotech growth beyond US partnerships Join us as these experts explore how Europe can leverage its scientific heritage to remain a global biotech leader. This conversation is packed with insights on the future of AI, international partnerships, and what it takes to keep innovation alive in Europe. 👀 Stay Tuned: Watch the full episode to see how Europe’s biotech ecosystem can thrive in the face of global competition and overcome its most pressing challenges. Send us Fan Mail Support the show Join the Podcast Newsletter: Link Your Next Move: Link

Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.

Hosts and Guests

Nobody is credited on this episode yet.

Credit the people on this episode

Be the first to rate this episode

More episodes

All episodes
  1. Spark 20: Alex Dang | Everyone Agrees? Think Again. How Venture Capitalists Decide

    Nov 1, 202629 minAudio

    Invest in the wrong startup and you lose one times your money. Miss the next Google and you lose ten thousand times. Most boards are built to avoid the first mistake. Venture capitalists play by different rules. They...

    Credit the people on this episode

  2. EP 185: Ivy Nguyen | IQ, EQ and the Execution Quotient Investors Fund

    Oct 18, 20261 hr 4 minAudio

    The trait a Silicon Valley AI investor rewards most in a management team has a name almost nobody uses: XQ. IQ brings the idea and EQ reads the people across the table. The execution quotient shows in something as small...

    Credit the people on this episode

  3. EP 184: Ivy Nguyen | 10,000 AI Pitches and the One Test That Matters

    Oct 15, 202659 minAudio

    In 2017 another investor told Ivy Nguyen that artificial intelligence was too small a niche to dedicate a fund to. More than ten thousand AI pitches later, every pitch deck says AI. Single funding rounds have grown...

    Credit the people on this episode

  4. EP 183: Marie Schroeder | Send the Rough Deck, Not the Perfect One

    Sep 27, 20262 hr 5 minAudio

    A seed investor at Novo Holdings would rather read your rough idea than your finished pitch deck. Most founders spend a year building the deck, forming the team and waiting until the story holds together. By the time it...

    Credit the people on this episode

  5. #182 - How to Lead When You Don't Know Where You Are Going: 4 Lessons from Ben Horowitz (Part 2 of 2)

    Sep 8, 202657 minAudio

    What does it mean when the most respected adviser in Silicon Valley tells you that you are the best chief executive he works with, while your company is heading straight into a wall? Bill Campbell said exactly that to...

    Credit the people on this episode